The agreement allows manufacturers to develop, manufacture and supply generic long-acting injectable cabotegravir for treatment in 133 countries.

Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...

Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.

As one FDA initiative works to sustain the momentum of rare disease research, other events threaten to slow progress.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...